Press release
Cushing’s Syndrome Therapeutics - Key Players Analysis Novartis, AstraZeneca, Cyclacel Pharmaceuticals, Inc., Angion Biomedica Corp.
Browse report sample at: https://www.psmarketresearch.com/market-analysis/cushing-syndrome-therapeutics-pipeline-analysis/report-sample
*Specific Targeted Therapy to Provide Various Opportunities
The drug development process involves specific target such as steroid 11-beta-hydroxylase, which is the probable mechanism of action for the treatment of Cushing’s syndrome. Thus, this specific targeted therapy provides opportunities to the companies for better and targeted drug development.
Some of the players developing drugs for the treatment of Cushing’s syndrome include Novartis AG, AstraZeneca Plc, Cyclacel Pharmaceuticals, Inc., and Angion Biomedica Corp.
Access Report Summary With Detailed TOC on “Cushing’s Syndrome Therapeutics - Pipeline Analysis 2017 at: https://www.psmarketresearch.com/market-analysis/cushing-syndrome-therapeutics-pipeline-analysis
*Insights on pipeline segments
Orphan drug designations from the European Medicines Agency (EMA) is the one of the drivers for the development of pipeline drugs of Cushing’s syndrome. Majority of the pipeline drug candidates are being developed using the oral route of administration. Osilodrostat which is being developed by the Novartis AG is in the Phase III stage of development for the treatment of Cushing’s syndrome.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cushing’s Syndrome Therapeutics - Key Players Analysis Novartis, AstraZeneca, Cyclacel Pharmaceuticals, Inc., Angion Biomedica Corp. here
News-ID: 1416989 • Views: …
More Releases from Prescient & Strategic Intelligence
Biobanking Services Market by Biobank Type, Service Type, Ownership, Application …
The global biobanking services market is expected to broaden during the forecast period, mainly on account of growing prevalence of chronic diseases, use of blood biomarkers in early detection of various types of cancersincreasing genomic research activities for studying diseases, growing trend of conserving cord blood stem cells of newborns, surging government and private funding to support regenerative medicine research, and growing need for cost-effective drug discovery and development.
Download free…
Patient Engagement Solutions Market 2013-2023 by Key Companies are - athenahealt …
The patient engagement solutions market for software is expected to reach $12.3 billion by 2023, registering a CAGR of 16.6% during the forecast period. Patient engagement software is increasingly being adopted by healthcare facilities, as it helps simplify complex patient health data and can also be customized according to requirements.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/patient-engagement-solutions-market/report-sample
During the forecast period, the patient engagement solutions market is expected to witness the highest demand…
Peptide Therapeutics Market 2024 with Top Key Players are Sanofi, Teva Pharmaceu …
The global peptide therapeutics market is growing significantly due to the increasing prevalence of cardiovascular diseases and cancer, advances in peptide therapeutics manufacturing technology, and increasing healthcare expenditure. In addition, growing research and development activities along with a rich peptide therapeutics pipeline is expected to support the growth of the peptide therapeutics market. Patent expiration of several peptide drugs in the coming years will create ample opportunities for the global…
ER+ Breast Cancer Pipeline to Witness Huge R&D Investment in the Coming Years | …
The study analyzed that the estrogen receptor positive breast cancer pipeline comprises approximately 74 drug candidates in different stages of development.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/estrogen-receptor-positive-breast-cancer-pipeline-analysis/report-sample
*Chemical Genomics-Based Discovery Platform for ER+ breast cancer drug development
Chipscreen Biosciences, Ltd. is using chemo genomics approach for the development of their drug candidates in ER+ breast cancer. The approach connects small molecule structures to disease targets and therapeutic functions to accelerate the discovery process…
More Releases for Cushing’s
Cushing’s syndrome Market Report Analysis With Industry Share
Cushing’s syndrome is the collection of symptoms caused due to the high level of hormones called cortisol. Also known as hypercortisolism, the syndrome is often caused due to side effects of corticosteroid treatment. Corticosteroids are often used for treatment of inflammation and autoimmune conditions. Cushing’s syndrome can be of two types, iatrogenic Cushing’s syndrome and endogenous Cushing’s syndrome. Common symptoms of the syndrome include weight gain, fat tissue deposits around…
Cushing’s syndrome Market Size & Share - Industry Trends and Forecast 2017 – …
Research Report on "Cushing’s syndrome Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025".
The objectives of this study are as follows:
To define, describe, and forecast the "Cushing’s syndrome " market by type, application, component, delivery model, end user, and region
To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
To analyze micromarkets with respect to individual growth trends, prospects, and…
Cushing’s Disease Treatment Market Expecting Worldwide Growth by 2025
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease…
Cushing’s syndrome Market: A Review of Recent Progresses and Future Directions
Cushing’s syndrome is the collection of symptoms caused due to the high level of hormones called cortisol. Also known as hypercortisolism, the syndrome is often caused due to side effects of corticosteroid treatment. Corticosteroids are often used for treatment of inflammation and autoimmune conditions. Cushing’s syndrome can be of two types, iatrogenic Cushing’s syndrome and endogenous Cushing’s syndrome. Common symptoms of the syndrome include weight gain, fat tissue deposits around…
Cushing’s Disease Treatment Market to Develop Rapidly by 2025
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease…
Cushing’s Disease Treatment Market Estimated to Soar Higher During 2017 - 2025
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease…
